Health Care [ 8/12 ] | Pharmaceuticals [ 50/74 ]
NASDAQ | Common Stock
Verona Pharma plc, a biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs.
The company offers Ohtuvayre, a dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that combines bronchodilator and non-steroidal anti-inflammatory effects for the maintenance treatment of chronic obstructive pulmonary disease, as well as cystic fibrosis and asthma.
Verona Pharma plc was incorporated in 2005 and is headquartered in London, the United Kingdom.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Feb 27, 25 | -0.40 Decreased by -122.22% | -0.15 Decreased by -166.67% |
| Nov 4, 24 | -0.56 Decreased by -211.11% | -0.50 Decreased by -12.00% |
| Aug 1, 24 | -0.88 Decreased by -1.00 K% | -0.37 Decreased by -137.84% |
| May 9, 24 | -0.32 Decreased by -966.67% | -0.16 Decreased by -100.00% |
| Feb 29, 24 | -0.18 Decreased by -12.50% | -0.26 Increased by +30.77% |
| Nov 2, 23 | -0.18 Increased by +21.74% | -0.28 Increased by +35.71% |
| Aug 3, 23 | -0.08 Increased by +75.00% | -0.29 Increased by +72.41% |
| May 9, 23 | -0.03 Increased by +92.50% | -0.19 Increased by +84.21% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 24 | 36.66 M Increased by +3.80 K% | -33.83 M Decreased by -137.30% | Decreased by -92.28% Increased by +93.91% |
| Sep 30, 24 | 5.62 M Increased by +N/A% | -42.96 M Decreased by -192.52% | Decreased by -763.90% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | -70.91 M Decreased by -705.21% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 24 | 0.00 Decreased by N/A% | -25.78 M Decreased by -53.97% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 23 | 940.06 K Increased by +105.25% | -14.25 M Decreased by -36.40% | Decreased by -1.52 K% Increased by +33.55% |
| Sep 30, 23 | 0.00 Decreased by N/A% | -14.69 M Increased by +6.14% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 23 | 0.00 Decreased by N/A% | -8.81 M Increased by +50.43% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 23 | 0.00 Decreased by N/A% | -16.74 M Increased by +32.59% | Decreased by N/A% Decreased by N/A% |